Official Title
Robotic Assisted Early Mobilization in Ventilated ICU Patients With COVID-19: an Interventional Randomized, Controlled Feasibility Study (ROBEM II Study)
Brief Summary

Feasibility trial investigating the potential higher frequency of robotic assisted early mobilization in intubated COVID19 patients on the ICU.

Completed
COVID19
Critical Illness
Critical Illness Polyneuromyopathy
Early Mobilization
Rehabilitation
Robotics

Device: Robotic assisted early mobilization

Robotic assisted early mobilization Robotic assisted early mobilization started within 72 hours of ICU admission.

Eligibility Criteria

Inclusion Criteria:

- Age ≥ 18 years

- Invasive mechanically ventilated and expected to be ventilated for another 24 hours

- Cardiovascular stability, allowing mobilization

- Respiratory stability, allowing mobilization

Exclusion Criteria:

- Bed-bound before ICU admission

- Bed-rest order or contraindication of weight load of the lower extremity or spine

- Severe skin lesions or fasciitis in the area of contact with the device or
rhabdomyolysis

- Fresh SAB, ICB or elevated ICP

- Status epilepticus

- Acute intoxication

- Shock with catecholamine doses >0.3μg/kg/min or acute bleeding including organ
ruptures

- Multiorgan failure with lactate > 4 mmol/l

- Body height outside the range 150-195 cm

- Body weight outside the range 45-135 kg

- pAVK IV°

- Pacemakers or other electrical stimulators

- Implanted medical pumps

- Pregnancy

- Life expectancy below 7 days or acute palliative care situation

- Death inevitable or maximum therapy is not carried out by the treating physicians or
due to patient's request

- Unable to understand the official language

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: 100 Years
Countries
Germany
Locations

Charité - Univiversitätsmedizin Berlin
Berlin-Mitte, Berlin, Germany

Stefan J Schaller, MD, Principal Investigator
Charite University, Berlin, Germany

Reactive Robotics GmbH
NCT Number
Keywords
COVID19
Early mobilization
robotics
Vemo
MeSH Terms
COVID-19
Critical Illness